• ̍̍ CSE: BRAX
  • ̍̍ OTC: BRAXF
  • ̍̍ FWB: 4960

Shareholders

October 29, 2021

Audio Webcast and Dial-In Number

Braxia Scientific Provides New Audio Webcast and Dial-In Number for Annual General Meeting TORONTO, ONTARIO, October 27, 2021 /CNW/ – Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, today provides revised details in connection with its annual general meeting of shareholders to be held on October 28, 2021, at 10:00 am (EST). The Company advises that the audio webcast and dial-in number for shareholders wishing to listen to the meeting have been changed from those provided in the notice of annual general meeting and information circular of the Company. The updated audio webcast and dial-in number is below: Audio Webcast Link: Click here for secure access Phone Number: +1-844-974-2903 Meeting Number: 2345 – 825 – 5938 Password: meet2021 Access Code: 234 – 582...

October 29, 2021

Voting Results from the Annual General Meeting

Braxia Scientific Announces Voting Results from the Annual General Meeting of Shareholders   TORONTO, ONTARIO October 29, 2021 – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce the voting results from its Annual General Meeting of Shareholders held on Thursday, October 28, 2021. A total of 11.77% of the issued and outstanding common shares of the Company were represented either in person or by proxy at the meeting. The following 4 nominees proposed by the Company were elected as Directors of Braxia Scientific to serve until the Company’s next Annual Meeting of Shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favor of individual nominees as follows:...